Katie Bitting, Ph.D., applies her broad expertise in chemical, biological, and medical sciences to draft and prosecute patents for clients in the chemical, pharmaceutical, and biotechnology industries.
Katie’s legal experience includes prosecuting patent applications for U.S. and international clients; drafting provisional, U.S. nonprovisional, and Patent Cooperation Treaty (PCT) applications; and performing patentability and due diligence searches. Her work for clients has encompassed a wide range of technologies and subject areas, including organic synthesis, chemical biology, molecular biology, immunology, animal models of disease, small molecule therapeutics, antisense oligonucleotides, CRISPR/Cas gene editing, genetically modified plants, materials and polymer chemistry, and batteries.
Prior to beginning her career in law, Katie served as an assistant professor of chemistry at West Virginia State University, where she taught organic chemistry and biochemistry, and as a postdoctoral researcher at North Carolina State University, where she studied the expression and signaling of MS4A proteins in response to type 2 inflammatory cytokines in mast cells and the development of therapeutics to treat allergic diseases, including asthma and atopic dermatitis. As a Ph.D. candidate at Duke University, her research in methodology developed new reactions for the synthesis of nitrogen-containing molecules, with a focus on the zincative functionalization of C–H bonds using lithium amide zincate bases and electrophilic amination.
